Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

ClinicalTrials.gov ID: NCT02159521

Public ClinicalTrials.gov record NCT02159521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ACCElerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy of ultrasound accelerated thrombolysis using the EkoSonic® Endovascular System with standard infusion of thrombolytic drug for post-thrombotic syndrome from chronic venous occlusion.

Study identification

NCT ID
NCT02159521
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
81 participants

Conditions and interventions

Interventions

Device · Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 10, 2014 (Actual)
Primary completion
Nov 30, 2017 (Actual)
Completion
Nov 30, 2017 (Actual)
Last update posted
Jul 19, 2021

2014 – 2017

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
21
Facility City State ZIP Site status
UCLA Medical Center Los Angeles California 90024 —
University of Colorado Hospital Aurora Colorado 80045 —
Vascular Breakthroughs Darien Connecticut 06820 —
Christiana Hospital Newark Delaware 19718 —
Tampa General Hospital Tampa Florida 33606 —
Piedmont Atlanta Hospital Atlanta Georgia 30309 —
Medical Center of Central Georgia Macon Georgia 31201 —
University of Louisville Research Foundation Louisville Kentucky 40202 —
Ochsner Medical Center New Orleans Louisiana 70121 —
Maine Medical Center Portland Maine 04106 —
University of Michigan Medical Center Ann Arbor Michigan 48109 —
CHI Health St. Elizabeth Lincoln Nebraska 68510 —
Holy Name Medical Center Teaneck New Jersey 07666 —
NYU Langone Medical Center New York New York 10016 —
Weill Cornell Medical Center New York New York 10024 —
Aultman Hospital Canton Ohio 44708 —
Fairfield Medical Center Lancaster Ohio 43130 —
Oregon Health & Science University Portland Oregon 97239 —
DFW Vascular Group/ Methodist Dallas Medical Ctr Dallas Texas 75208 —
Houston Methodist Sugar Land Hospital Sugar Land Texas 77479 —
Inova Alexandria Hospital Alexandria Virginia 22304 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02159521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02159521 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →